Crosstalk between myocardial autophagy and sterile inflammation in the development of heart failure

References

• Spencer LJ, Degu A, Kalkidan HA, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789–52. doi: 10.1016/S0140-6736(18)32279-7
   Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):e240–327.
   PubMed Web of Science ®Google Scholar
• Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017 Jan;14(1):30–38.
   PubMed Web of Science ®Google Scholar
• Wu MY, Yiang GT, Liao WT, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem. 2018;46(4):1650–1667. doi: 10.1159/000489241
   PubMedGoogle Scholar
• Nagalingam RS, Chattopadhyaya S, Al-Hattab DS, et al. Scleraxis and fibrosis in the pressure-overloaded heart. Eur Heart J. 2022 Dec 1;43(45):4739–4750.
   Web of Science ®Google Scholar
• Mizushima N, Levine B, Longo DL. Autophagy in Human Diseases. N Engl J Med. 2020 Oct 15;383(16):1564–1576
   PubMed Web of Science ®Google Scholar
• Delbridge LMD, Mellor KM, Taylor DJ, et al. Myocardial stress and autophagy: mechanisms and potential therapies. Nat Rev Cardiol. 2017 Jul;14(7):412–425. doi: 10.1038/nrcardio.2017.35
   PubMed Web of Science ®Google Scholar
• Jahng JW, Turdi S, Kovacevic V, et al. Pressure Overload-Induced Cardiac Dysfunction in Aged Male Adiponectin Knockout Mice Is Associated With Autophagy Deficiency. Endocrinology. 2015 Jul;156(7):2667–2677. doi: 10.1210/en.2015-1162
   PubMed Web of Science ®Google Scholar
• Ma X, Liu H, Foyil SR, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation. 2012 Jun 26;125(25):3170–3181.
   PubMed Web of Science ®Google Scholar
• Mariño G, Pietrocola F, Kong Y, et al. Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy. Autophagy. 2014 May;10(5):930–932. doi: 10.4161/auto.28235
   PubMed Web of Science ®Google Scholar
• Shirakabe A, Zhai P, Ikeda Y, et al. Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure. Circulation. 2016 Mar 29;133(13):1249–1263.
   PubMed Web of Science ®Google Scholar
• Wellnitz K, Taegtmeyer H. Mechanical unloading of the failing heart exposes the dynamic nature of autophagy. Autophagy. 2010 Jan;6(1):155–156.
   PubMed Web of Science ®Google Scholar
• Meng X, Yang J, Dong M, et al. Regulatory T cells in cardiovascular diseases. Nat Rev Cardiol. 2016 Mar;13(3):167–179. doi: 10.1038/nrcardio.2015.169
   PubMed Web of Science ®Google Scholar
• Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017 Mar 15;113(4):389–398.
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res. 2019 Jan 18;124(2):315–327.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bauersachs J, Langer HF. Immune mechanisms in heart failure. Eur J Heart Fail. 2017 Nov;19(11):1379–1389.
   Web of Science ®Google Scholar
• Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015 Feb;15(2):117–129.
   PubMed Web of Science ®Google Scholar
• Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010 Dec;10(12):826–837.
   PubMed Web of Science ®Google Scholar
• Gong T, Liu L, Jiang W, et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020 Feb;20(2):95–112. doi: 10.1038/s41577-019-0215-7
   PubMed Web of Science ®Google Scholar
• Kologrivova I, Shtatolkina M, Suslova T, et al. Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction. Front Immunol. 2021;12:664457.
   PubMed Web of Science ®Google Scholar
• Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016 Aug;15(8):551–567.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang H, Li J. Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword. Clin Med Insights Cardiol. 2016;10:79–84.
   PubMed Web of Science ®Google Scholar
• Saparov A, Ogay V, Nurgozhin T, et al. Role of the immune system in cardiac tissue damage and repair following myocardial infarction. Inflamm Res. 2017 Sep;66(9):739–751. doi: 10.1007/s00011-017-1060-4
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Bergamini E, Brunk UT, et al. Autophagy and aging: the importance of maintaining “clean” cells. Autophagy. 2005 Oct-Dec;1(3):131–140. doi: 10.4161/auto.1.3.2017
   PubMed Web of Science ®Google Scholar
• Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018 Jun;19(6):365–381.
   PubMed Web of Science ®Google Scholar
• Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci. 2012 Apr;69(7):1125–1136.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008 Jan 11;132(1):27–42.
   PubMed Web of Science ®Google Scholar
• Wang L, Klionsky DJ, Shen HM. The emerging mechanisms and functions of microautophagy. Nat Rev Mol Cell Biol. 2023 Mar;24(3):186–203.
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Maejima Y, Zablocki D, et al. The Role of Autophagy in the Heart. Annu Rev Physiol. 2018 Feb 10;80(1):1–26.
   PubMedGoogle Scholar
• Wesselborg S, Stork B. Autophagy signal transduction by ATG proteins: from hierarchies to networks. Cell Mol Life Sci. 2015 Dec;72(24):4721–4757.
   PubMed Web of Science ®Google Scholar
• Diaz-Troya S, Perez-Perez ME, Florencio FJ, et al. The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy. 2008 Oct;4(7):851–865. doi: 10.4161/auto.6555
   PubMed Web of Science ®Google Scholar
• Banreti A, Sass M, Graba Y. The emerging role of acetylation in the regulation of autophagy. Autophagy. 2013 Jun 1;9(6):819–829.
   PubMed Web of Science ®Google Scholar
• Lin MG, Hurley JH. Structure and function of the ULK1 complex in autophagy. Curr Opin Cell Biol. 2016 Apr;39:61–68.
   PubMed Web of Science ®Google Scholar
• Martinez-Lopez N, Singh R. ATGs: Scaffolds for MAPK/ERK signaling. Autophagy. 2014 Mar;10(3):535–537.
   PubMed Web of Science ®Google Scholar
• Zhou F, Wu Z, Zhao M, et al. Rab5-dependent autophagosome closure by ESCRT. J Cell Biol. 2019 Jun 3;218(6):1908–1927.
   PubMed Web of Science ®Google Scholar
• Tian X, Teng J, Chen J. New insights regarding SNARE proteins in autophagosome-lysosome fusion. Autophagy. 2021 Oct;17(10):2680–2688.
   PubMed Web of Science ®Google Scholar
• Langemeyer L, Frohlich F, Ungermann C. Rab GTPase Function in Endosome and Lysosome Biogenesis. Trends Cell Biol. 2018 Nov;28(11):957–970.
   PubMed Web of Science ®Google Scholar
• Yang Z, Huang J, Geng J, et al. Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol Biol Cell. 2006 Dec;17(12):5094–5104. doi: 10.1091/mbc.e06-06-0479
   PubMed Web of Science ®Google Scholar
• Diao J, Liu R, Rong Y, et al. ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature. 2015 Apr 23;520(7548):563–566.
   PubMed Web of Science ®Google Scholar
• Qiao L, Hu J, Qiu X, et al. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. Autophagy. 2023 Nov;19(11):2837–2852. doi: 10.1080/15548627.2023.2235196
   PubMed Web of Science ®Google Scholar
• Szatmari Z, Sass M. The autophagic roles of Rab small GTPases and their upstream regulators: a review. Autophagy. 2014 Jul;10(7):1154–1166.
   PubMed Web of Science ®Google Scholar
• Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Nat Cell Biol. 2018 Mar;20(3):233–242.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Kumanomidou T, Sou YS, et al. Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem. 2008 Aug 15;283(33):22847–22857.
   PubMed Web of Science ®Google Scholar
• Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005;8(1): 3–5. Spring. doi: 10.1089/rej.2005.8.3.
   PubMed Web of Science ®Google Scholar
• Hirota Y, Yamashita S, Kurihara Y, et al. Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. 2015;11(2):332–343. doi: 10.1080/15548627.2015.1023047
   PubMed Web of Science ®Google Scholar
• Geisler S, Holmstrom KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010 Feb;12(2):119–131. doi: 10.1038/ncb2012
   PubMed Web of Science ®Google Scholar
• Sadoshima J. Alternative mitophagy is a major form of mitophagy in the chronically stressed heart. Autophagy. 2022 Sep;18(9):2252–2253.
   PubMed Web of Science ®Google Scholar
• Saito T, Nah J, Oka SI, et al. An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia. J Clin Invest. 2019 Feb 1;129(2):802–819.
   Web of Science ®Google Scholar
• Liu L, Feng D, Chen G, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012 Jan 22;14(2):177–185.
   PubMed Web of Science ®Google Scholar
• Gibbings D, Mostowy S, Jay F, et al. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol. 2012 Dec;14(12):1314–1321. doi: 10.1038/ncb2611
   PubMed Web of Science ®Google Scholar
• Gatica D, Chiong M, Lavandero S, et al. Molecular mechanisms of autophagy in the cardiovascular system. Circ Res. 2015 Jan 30;116(3):456–467.
   PubMed Web of Science ®Google Scholar
• Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in Cardiovascular Disease. Circ Res. 2017 May 26;120(11):1812–1824.
   PubMed Web of Science ®Google Scholar
• Lavandero S, Troncoso R, Rothermel BA, et al. Cardiovascular autophagy: concepts, controversies, and perspectives. Autophagy. 2013 Oct;9(10):1455–1466. doi: 10.4161/auto.25969
   PubMed Web of Science ®Google Scholar
• Morales PE, Arias-Duran C, Avalos-Guajardo Y, et al. Emerging role of mitophagy in cardiovascular physiology and pathology. Mol Aspects Med. 2020 Feb;71:100822.
   PubMed Web of Science ®Google Scholar
• Bergmann O, Zdunek S, Felker A, et al. Dynamics of Cell Generation and Turnover in the Human Heart. Cell. 2015 Jun 18;161(7):1566–1575.
   PubMed Web of Science ®Google Scholar
• Shirakabe A, Ikeda Y, Sciarretta S, et al. Aging and Autophagy in the Heart. Circ Res. 2016 May 13;118(10):1563–1576.
   PubMed Web of Science ®Google Scholar
• Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007 May 13(5):619–624. doi: 10.1038/nm1574
   PubMed Web of Science ®Google Scholar
• Onishi M, Yamano K, Sato M, et al. Molecular mechanisms and physiological functions of mitophagy. Embo j. 2021 Feb 1;40(3):e104705.
   PubMed Web of Science ®Google Scholar
• Luan Y, Luan Y, Feng Q, et al. Emerging Role of Mitophagy in the Heart: Therapeutic Potentials to Modulate Mitophagy in Cardiac Diseases. Oxid Med Cell Longev. 2021;2021:3259963.
   PubMed Web of Science ®Google Scholar
• Gurkar AU, Chu K, Raj L, et al. Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress. Nat Commun. 2013;4(1):2189. doi: 10.1038/ncomms3189
   PubMedGoogle Scholar
• Sciarretta S, Zhai P, Shao D, et al. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation. 2012 Mar 6;125(9):1134–1146.
   Web of Science ®Google Scholar
• Abdellatif M, Sedej S, Carmona-Gutierrez D, et al. Autophagy in Cardiovascular Aging. Circ Res. 2018 Sep 14;123(7):803–824.
   PubMed Web of Science ®Google Scholar
• Zhai P, Sadoshima J. Glycogen synthase kinase-3β controls autophagy during myocardial ischemia and reperfusion. Autophagy. 2012 Jan;8(1):138–139.
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Yee D, Nagarajan N, et al. Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction. J Am Coll Cardiol. 2018 May 8;71(18):1999–2010.
   PubMed Web of Science ®Google Scholar
• Valentim L, Laurence KM, Townsend PA, et al. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol. 2006 Jun;40(6):846–852. doi: 10.1016/j.yjmcc.2006.03.428
   PubMed Web of Science ®Google Scholar
• Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007 Mar 30;100(6):914–922.
   PubMed Web of Science ®Google Scholar
• Ma X, Liu H, Foyil SR, et al. Autophagy is impaired in cardiac ischemia-reperfusion injury. Autophagy. 2012 Sep;8(9):1394–1396. doi: 10.4161/auto.21036
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Zhai P, Shao D, et al. Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2alpha/activating transcription factor 4 pathway. Circ Res. 2013 Nov 8;113(11):1253–1264.
   PubMed Web of Science ®Google Scholar
• Matsushima S, Kuroda J, Zhai P, et al. Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling. J Clin Invest. 2016 Sep 1;126(9):3403–3416.
   PubMed Web of Science ®Google Scholar
• Yan L, Vatner DE, Kim SJ, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13807–13812.
   PubMed Web of Science ®Google Scholar
• Huang L, Dai K, Chen M, et al. The AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy. J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):70–81. doi: 10.1177/1074248415581177
   PubMed Web of Science ®Google Scholar
• Li S, Liu C, Gu L, et al. Autophagy protects cardiomyocytes from the myocardial ischaemia-reperfusion injury through the clearance of CLP36. Open Biol. 2016 Aug;6(8):160177. doi: 10.1098/rsob.160177
   Web of Science ®Google Scholar
• Kanamori H, Takemura G, Goto K, et al. Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2261–H2271. doi: 10.1152/ajpheart.01056.2010
   PubMed Web of Science ®Google Scholar
• Wei YM, Li X, Xu M, et al. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem. 2013;31(6):925–937. doi: 10.1159/000350111
   PubMedGoogle Scholar
• Nah J, Zhai P, Huang CY, et al. Upregulation of Rubicon promotes autosis during myocardial ischemia/reperfusion injury. J Clin Invest. 2020 Jun 1;130(6):2978–2991.
   PubMed Web of Science ®Google Scholar
• Wu S, Chang G, Gao L, et al. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy. J Mol Med (Berl). 2018 Aug 96(8):791–806. doi: 10.1007/s00109-018-1664-3
   PubMed Web of Science ®Google Scholar
• Hall AR, Burke N, Dongworth RK, et al. Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction. Cell Death Dis. 2016 May 26;7(5):e2238–e2238.
   PubMedGoogle Scholar
• Ong SB, Subrayan S, Lim SY, et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 2010 May 11;121(18):2012–2022.
   PubMed Web of Science ®Google Scholar
• Diwan A, Krenz M, Syed FM, et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest. 2007 Oct;117(10):2825–2833. doi: 10.1172/JCI32490
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhu P, Wang J, et al. Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy. Cell Death Differ. 2018 Jun;25(6):1080–1093. doi: 10.1038/s41418-018-0086-7
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu P, Li R, et al. Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission. Redox Biol. 2020 Feb;30:101415.
   PubMed Web of Science ®Google Scholar
• Sanz J, Sánchez-Quintana D, Bossone E, et al. Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 Apr 2;73(12):1463–1482.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jaswal JS, Ussher JR, et al. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ Heart Fail. 2013 Sep 1;6(5):1039–1048.
   PubMed Web of Science ®Google Scholar
• Huo S, Shi W, Ma H, et al. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene. Oxid Med Cell Longev. 2021;2021:6699054.
   PubMed Web of Science ®Google Scholar
• Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest. 2007 Jul;117(7):1782–1793. doi: 10.1172/JCI27523
   PubMed Web of Science ®Google Scholar
• Cao Z, Liu J, Zhao Z, et al. miR-16-5p Regulates PTPN4 and Affects Cardiomyocyte Apoptosis and Autophagy Induced by Hypoxia/Reoxygenation. Evid Based Complement Alternat Med. 2021;2021:5599031.
   Web of Science ®Google Scholar
• Nah J, Shirakabe A, Mukai R, et al. Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart. Cardiovasc Res. 2022 Sep 20;118(12):2638–2651.
   Web of Science ®Google Scholar
• Li W, Yin L, Sun X, et al. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell Death Dis. 2020 Jul 30;11(7):599.
   Web of Science ®Google Scholar
• Saito T, Hamano K, Sadoshima J. Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart. Cardiovasc Res. 2021 Dec 17;117(14):2730–2741.
   Web of Science ®Google Scholar
• Wang X, Guo Z, Ding Z, et al. Inflammation, Autophagy, and Apoptosis After Myocardial Infarction. J Am Heart Assoc. 2018 Apr 21;7(9). doi: 10.1161/JAHA.117.008024
   Web of Science ®Google Scholar
• Lopez-Crisosto C, Pennanen C, Vasquez-Trincado C, et al. Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology. Nat Rev Cardiol. 2017 Jun 14(6):342–360. doi: 10.1038/nrcardio.2017.23
   PubMed Web of Science ®Google Scholar
• Rothermel BA, Hill JA. Autophagy in load-induced heart disease. Circ Res. 2008 Dec 5;103(12):1363–1369
   Web of Science ®Google Scholar
• Wu D, Zhang K, Hu P. The Role of Autophagy in Acute Myocardial Infarction. Front Pharmacol. 2019;10:551.
   PubMed Web of Science ®Google Scholar
• Li L, Fu W, Gong X, et al. The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction. Eur Heart J. 2021 Apr 7;42(14):1415–1430.
   Web of Science ®Google Scholar
• Wu X, He L, Chen F, et al. Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS One. 2014;9(11):e112891. doi: 10.1371/journal.pone.0112891
   PubMed Web of Science ®Google Scholar
• Wu X, Zheng D, Qin Y, et al. Nobiletin attenuates adverse cardiac remodeling after acute myocardial infarction in rats via restoring autophagy flux. Biochem Biophys Res Commun. 2017 Oct 14;492(2):262–268.
   Web of Science ®Google Scholar
• Zhang X, Wang Q, Wang X, et al. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway. Biomed Pharmacother. 2019 Apr;112:108599.
   PubMed Web of Science ®Google Scholar
• Wang D, Lv L, Xu Y, et al. Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomed Pharmacother. 2021 Apr 136:111287.
   PubMed Web of Science ®Google Scholar
• Foglio E, Puddighinu G, Germani A, et al. HMGB1 Inhibits Apoptosis Following MI and Induces Autophagy via mTORC1 Inhibition. J Cell Physiol. 2017 May;232(5):1135–1143. doi: 10.1002/jcp.25576
   Web of Science ®Google Scholar
• Buss SJ, Riffel JH, Katus HA, et al. Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters. Autophagy. 2010 Feb;6(2):304–306. doi: 10.4161/auto.6.2.11135
   PubMed Web of Science ®Google Scholar
• Ramachandra CJA, Hernandez-Resendiz S, Crespo-Avilan GE, et al. Mitochondria in acute myocardial infarction and cardioprotection. EBioMedicine. 2020 Jul;57:102884.
   PubMed Web of Science ®Google Scholar
• Ajoolabady A, Chiong M, Lavandero S, et al. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment. Trends Mol Med. 2022 Oct;28(10):836–849. doi: 10.1016/j.molmed.2022.06.007
   Web of Science ®Google Scholar
• Marinkovic M, Sprung M, Novak I. Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery. Autophagy. 2021 May;17(5):1232–1243.
   PubMed Web of Science ®Google Scholar
• Lampert MA, Orogo AM, Najor RH, et al. BNIP3L/NIX and FUNDC1-mediated mitophagy is required for mitochondrial network remodeling during cardiac progenitor cell differentiation. Autophagy. 2019 Jul;15(7):1182–1198. doi: 10.1080/15548627.2019.1580095
   PubMed Web of Science ®Google Scholar
• Hoshino A, Matoba S, Iwai-Kanai E, et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol. 2012 Jan;52(1):175–184. doi: 10.1016/j.yjmcc.2011.10.008
   PubMed Web of Science ®Google Scholar
• Chen G, Han Z, Feng D, et al. A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol Cell. 2014 May 8;54(3):362–377.
   PubMed Web of Science ®Google Scholar
• Zhang W, Ren H, Xu C, et al. Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury. Elife. 2016 Dec 20;5. 5. doi: 10.7554/eLife.21407
   Web of Science ®Google Scholar
• Ji W, Wei S, Hao P, et al. Aldehyde Dehydrogenase 2 Has Cardioprotective Effects on Myocardial Ischaemia/Reperfusion Injury via Suppressing Mitophagy. Front Pharmacol. 2016;7:101.
   PubMed Web of Science ®Google Scholar
• Xin T, Lu C. Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction. Aging (Albany NY). 2020 Mar 10;12(5):4474–4488.
   PubMedGoogle Scholar
• Kubli DA, Zhang X, Lee Y, et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J Biol Chem. 2013 Jan 11;288(2):915–926.
   PubMed Web of Science ®Google Scholar
• Kanamori H, Takemura G, Goto K, et al. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes. Autophagy. 2015;11(7):1146–1160. doi: 10.1080/15548627.2015.1051295
   PubMed Web of Science ®Google Scholar
• Madonna R, Moscato S, Cufaro MC, et al. Empagliflozin inhibits excessive autophagy through the AMPK/GSK3beta signalling pathway in diabetic cardiomyopathy. Cardiovasc Res. 2023 May 22;119(5):1175–1189.
   Web of Science ®Google Scholar
• Wang Y, Liang B, Lau WB, et al. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling. Autophagy. 2017;13(11):1855–1869. doi: 10.1080/15548627.2017.1358848
   PubMed Web of Science ®Google Scholar
• Tong M, Saito T, Zhai P, et al. Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy. Circ Res. 2019 Apr 26;124(9):1360–1371.
   PubMed Web of Science ®Google Scholar
• Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008 Feb 29;102(4):401–414.
   PubMed Web of Science ®Google Scholar
• Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, et al. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018 Jan 25;9(2):119.
   PubMed Web of Science ®Google Scholar
• Wilson AJ, Gill EK, Abudalo RA, et al. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Heart. 2018 Feb;104(4):293–299. doi: 10.1136/heartjnl-2017-311448
   PubMed Web of Science ®Google Scholar
• Sung MM, Hamza SM, Dyck JR. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets. Antioxid Redox Signal. 2015 Jun 10;22(17):1606–1630.
   Web of Science ®Google Scholar
• Xu X, Hua Y, Nair S, et al. Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J Mol Cell Biol. 2013 Feb;5(1):61–63. doi: 10.1093/jmcb/mjs055
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu J, Long J. Phosphatase and tensin homolog-induced putative kinase 1 and Parkin in diabetic heart: Role of mitophagy. J Diabetes Investig. 2015 May;6(3):250–255.
   PubMed Web of Science ®Google Scholar
• Nishida Y, Arakawa S, Fujitani K, et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature. 2009 Oct 1;461(7264):6548.
   Web of Science ®Google Scholar
• Andonegui G, Zhou H, Bullard D, et al. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest. 2009 Jul;119(7):1921–1930. doi: 10.1172/jci36411
   Web of Science ®Google Scholar
• Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008 Jul;48(1):322–335.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao XM, Fang L, et al. Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):834–841. doi: 10.1161/ATVBAHA.110.220467
   PubMed Web of Science ®Google Scholar
• Gurses KM, Kocyigit D, Yalcin MU, et al. Enhanced Platelet Toll-like Receptor 2 and 4 Expression in Acute Coronary Syndrome and Stable Angina Pectoris. Am J Cardiol. 2015 Dec 1;116(11):1666–1671.
   PubMed Web of Science ®Google Scholar
• Schanze N, Bode C, Duerschmied D. Platelet Contributions to Myocardial Ischemia/Reperfusion Injury. Front Immunol. 2019;10:1260.
   Web of Science ®Google Scholar
• Mirabet M, Garcia-Dorado D, Inserte J, et al. Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts. Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H1134–H1141. doi: 10.1152/ajpheart.00065.2002
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Ma XY, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 1993 Jun;91(6):2620–2629. doi: 10.1172/JCI116501
   Web of Science ®Google Scholar
• Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012 Mar 1;4(3):a006049–a006049.
   PubMed Web of Science ®Google Scholar
• Yanai H, Ban T, Wang Z, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009 Nov 5;462(7269):99–103.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Livesey KM, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol. 2010 Sep 6;190(5):881–892.
   PubMed Web of Science ®Google Scholar
• Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005 Apr 4;201(7):1135–1143.
   PubMed Web of Science ®Google Scholar
• Kim S, Kim SY, Pribis JP, et al. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol Med. 2013 May 20;19(1):88–98.
   Google Scholar
• Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28(1):367–388. doi: 10.1146/annurev.immunol.021908.132603
   PubMed Web of Science ®Google Scholar
• Ling Y, Yang ZY, Yin T, et al. Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro. Int Immunopharmacol. 2011 Feb;11(2):187–193. doi: 10.1016/j.intimp.2010.11.014
   PubMed Web of Science ®Google Scholar
• He M, Bianchi ME, Coleman TR, et al. Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance. Mol Med. 2018 May 10;24(1):21.
   PubMedGoogle Scholar
• Tang D, Shi Y, Kang R, et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol. 2007 Mar;81(3):741–747. doi: 10.1189/jlb.0806540
   Web of Science ®Google Scholar
• Andreeva L, Hiller B, Kostrewa D, et al. cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders. Nature. 2017 Sep 21;549(7672):394–398.
   Web of Science ®Google Scholar
• Tirone M, Tran NL, Ceriotti C, et al. High mobility group box 1 orchestrates tissue regeneration via CXCR4. J Exp Med. 2018 Jan 2;215(1):303–318.
   Web of Science ®Google Scholar
• Yan C, Duanmu X, Zeng L, et al. Mitochondrial DNA: Distribution, Mutations, and Elimination. Cells. 2019 Apr 25;8(4):379.
   Web of Science ®Google Scholar
• Picca A, Lezza AM. Regulation of mitochondrial biogenesis through TFAM-mitochondrial DNA interactions: Useful insights from aging and calorie restriction studies. Mitochondrion. 2015 Nov;25:67–75.
   PubMed Web of Science ®Google Scholar
• Bonawitz ND, Clayton DA, Shadel GS. Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol Cell. 2006 Dec 28;24(6):813–825.
   Web of Science ®Google Scholar
• Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012 Mar 23;36(3):401–414.
   PubMed Web of Science ®Google Scholar
• Ohto U, Shibata T, Tanji H, et al. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature. 2015 Apr 30;520(7549):702–705.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Liang S, Sanchez-Lopez E, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018 Aug;560(7717):198–203. doi: 10.1038/s41586-018-0372-z
   PubMed Web of Science ®Google Scholar
• Xian H, Watari K, Sanchez-Lopez E, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022 Aug 9;55(8):1370–1385.e8.
   Web of Science ®Google Scholar
• Aarreberg LD, Esser-Nobis K, Driscoll C, et al. Interleukin-1β Induces mtDNA Release to Activate Innate Immune Signaling via cGAS-STING. Mol Cell. 2019 May 16;74(4):801–815.e6.
   PubMed Web of Science ®Google Scholar
• Marchi S, Guilbaud E, Tait SWG, et al. Mitochondrial control of inflammation. Nat Rev Immunol. 2023 Mar;23(3):159–173. doi: 10.1038/nrmicro2070
   PubMed Web of Science ®Google Scholar
• Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016 Jul;16(7):407–420.
   PubMed Web of Science ®Google Scholar
• Mauro AG, Bonaventura A, Mezzaroma E, et al. NLRP3 Inflammasome in Acute Myocardial Infarction. J Cardiovasc Pharmacol. 2019 Sep;74(3):175–187. doi: 10.1097/FJC.0000000000000717
   Web of Science ®Google Scholar
• Mishra SR, Mahapatra KK, Behera BP, et al. Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int J Biochem Cell Biol. 2021 Jul;136:106013.
   PubMed Web of Science ®Google Scholar
• Jo EK, Kim JK, Shin DM, et al. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016 Mar;13(2):148–159. doi: 10.1038/cmi.2015.95
   PubMed Web of Science ®Google Scholar
• Rock KL, Latz E, Ontiveros F, et al. The sterile inflammatory response. Annu Rev Immunol. 2010;28(1):321–342. doi: 10.1146/annurev-immunol-030409-101311.
   PubMedGoogle Scholar
• Kawaguchi M, Takahashi M, Hata T, et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation. 2011 Feb 15;123(6):594–604.
   PubMed Web of Science ®Google Scholar
• Toldo S, Mezzaroma E, Buckley LF, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022 Aug;236:108053.
   Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009 Feb;7(2):99–109.
   PubMed Web of Science ®Google Scholar
• Toldo S, Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol. 2018 Apr;15(4):203–214.
   PubMed Web of Science ®Google Scholar
• Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010 Nov;14(11):2592–2603.
   PubMed Web of Science ®Google Scholar
• Walsh MC, Lee J, Choi Y. Tumor necrosis factor receptor-associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev. 2015 Jul;266(1):72–92.
   PubMed Web of Science ®Google Scholar
• Mitchell S, Vargas J, Hoffmann A. Signaling via the NFkappaB system. Wiley Interdiscip Rev Syst Biol Med. 2016 May;8(3):227–241.
   PubMed Web of Science ®Google Scholar
• Feldman N, Rotter-Maskowitz A, Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev. 2015 Nov;24(Pt A):29–39.
   Google Scholar
• Ullah MO, Sweet MJ, Mansell A, et al. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. J Leukoc Biol. 2016 Jul;100(1):27–45. doi: 10.1189/jlb.2RI1115-531R
   PubMed Web of Science ®Google Scholar
• Chen JQ, Szodoray P, Zeher M. Toll-Like Receptor Pathways in Autoimmune Diseases. Clin Rev Allergy Immunol. 2016 Feb;50(1):1–17.
   PubMed Web of Science ®Google Scholar
• Castiglione V, Aimo A, Vergaro G, et al. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev. 2022 Mar;27(2):625–643. doi: 10.1007/s10741-021-10105-w
   PubMed Web of Science ®Google Scholar
• Coggins M, Rosenzweig A. The fire within: cardiac inflammatory signaling in health and disease. Circ Res. 2012 Jan 6;110(1):116–125.
   PubMed Web of Science ®Google Scholar
• Marchant DJ, Boyd JH, Lin DC, et al. Inflammation in myocardial diseases. Circ Res. 2012 Jan 6;110(1):126–144.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008 Jul 24;454(7203):428–435.
   PubMed Web of Science ®Google Scholar
• Maekawa Y, Anzai T, Yoshikawa T, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol. 2002 Jan 16;39(2):241–246.
   PubMed Web of Science ®Google Scholar
• Arslan F, Smeets MB, O’Neill LA, et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation. 2010 Jan 5;121(1):80–90.
   PubMed Web of Science ®Google Scholar
• Sakata Y, Dong JW, Vallejo JG, et al. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H503–H509. doi: 10.1152/ajpheart.00642.2006
   Web of Science ®Google Scholar
• Fairweather D, Yusung S, Frisancho S, et al. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol. 2003 May 1;170(9):4731–4737.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002 Jul 11;418(6894):191–195.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005 Apr;5(4):331–342.
   PubMed Web of Science ®Google Scholar
• Kohno T, Anzai T, Naito K, et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res. 2009 Feb 15;81(3):565–573.
   PubMed Web of Science ®Google Scholar
• Goldstein RS, Gallowitsch-Puerta M, Yang L, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 2006 Jun;25(6):571–574. doi: 10.1097/01.shk.0000209540.99176.72
   PubMed Web of Science ®Google Scholar
• Bradham WS, Bozkurt B, Gunasinghe H, et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res. 2002 Mar;53(4):822–830. doi: 10.1016/S0008-6363(01)00503-X
   PubMed Web of Science ®Google Scholar
• Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 Jul 26;323(4):236–241.
   PubMed Web of Science ®Google Scholar
• Merkle S, Frantz S, Schön MP, et al. A role for caspase-1 in heart failure. Circ Res. 2007 Mar 16;100(5):645–653.
   Web of Science ®Google Scholar
• Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001 Apr 24;103(16):2055–2059.
   PubMed Web of Science ®Google Scholar
• Bracey NA, Beck PL, Muruve DA, et al. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β. Exp Physiol. 2013 Feb;98(2):462–472. doi: 10.1113/expphysiol.2012.068338
   Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017 Sep 21;377(12):1119–1131.
   PubMed Web of Science ®Google Scholar
• Chung ES, Packer M, Lo KH, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003 Jul 1;107(25):3133–3140.
   PubMed Web of Science ®Google Scholar
• Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004 Apr 6;109(13):1594–1602.
   PubMed Web of Science ®Google Scholar
• Lutgens E, Daemen MJAP, de Muinck ED, et al. Chronic myocardial infarction in the mouse: cardiac structural and functional change1. Cardiovasc Res. 1999;41(3):586–593. doi: 10.1016/S0008-6363(98)00216-8
   Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018 Nov 13;138(20):e618–e651.
   PubMed Web of Science ®Google Scholar
• Bliksøen M, Mariero LH, Torp MK, et al. Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes. Basic Res Cardiol. 2016 Jul;111(4):42. doi: 10.1007/s00395-016-0553-6
   Web of Science ®Google Scholar
• Krysko DV, Agostinis P, Krysko O, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011 Apr;32(4):157–164. doi: 10.1016/j.it.2011.01.005
   PubMed Web of Science ®Google Scholar
• Lipps C, Nguyen JH, Pyttel L, et al. N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro. J Mol Cell Cardiol. 2016 Oct;99:47–56.
   Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016 Jun 24;119(1):91–112.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Rosenzweig A. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012 Jan 6;110(1):159–173.
   PubMed Web of Science ®Google Scholar
• Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res. 2011 Apr 29;108(9):1122–1132.
   PubMed Web of Science ®Google Scholar
• Bujak M, Dobaczewski M, Chatila K, et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008 Jul;173(1):57–67. doi: 10.2353/ajpath.2008.070974
   PubMed Web of Science ®Google Scholar
• Müller J, Gorressen S, Grandoch M, et al. Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction. Basic Res Cardiol. 2014;109(6):440. doi: 10.1007/s00395-014-0440-y
   PubMed Web of Science ®Google Scholar
• Lindsey ML, Bolli R, Canty JM Jr, et al. Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H812–H838.
   Web of Science ®Google Scholar
• Armstrong PW, Collen D, Antman E. Fibrinolysis for acute myocardial infarction: the future is here and now. Circulation. 2003 May 27;107(20):2533–2537.
   Web of Science ®Google Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 3;141(9):e139–e596.
   PubMed Web of Science ®Google Scholar
• Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017 Mar 14;38(11):774–784.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Bratton DL, Colgan SP. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov. 2014 Nov;13(11):852–869.
   PubMed Web of Science ®Google Scholar
• Lin L, Knowlton AA. Innate immunity and cardiomyocytes in ischemic heart disease. Life Sci. 2014 Mar 28;100(1):1–8.
   Web of Science ®Google Scholar
• Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014 May;11(5):255–265.
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Ryffel B, Quesniaux VF, et al. Role of pattern-recognition receptors in cardiovascular health and disease. Biochem Soc Trans. 2007 Dec;35(Pt 6):1449–1452. doi: 10.1042/BST0351449
   PubMed Web of Science ®Google Scholar
• Suetomi T, Willeford A, Brand CS, et al. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca(2+)/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation. 2018 Nov 27;138(22):2530–2544.
   PubMed Web of Science ®Google Scholar
• Christia P, Frangogiannis NG. Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest. 2013 Sep;43(9):986–995.
   PubMed Web of Science ®Google Scholar
• Turillazzi E, Di Paolo M, Neri M, et al. A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers. J Transl Med. 2014 Jul 2;12(1):188.
   Google Scholar
• Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013 May;5(5):661–674.
   PubMed Web of Science ®Google Scholar
• Mouton AJ, DeLeon-Pennell KY, Rivera Gonzalez OJ, et al. Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol. 2018 Jun 4;113(4):26.
   PubMed Web of Science ®Google Scholar
• Frantz S, Bauersachs J, Ertl G. Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res. 2009 Feb 15;81(3):474–481.
   PubMed Web of Science ®Google Scholar
• Riley JS, Quarato G, Cloix C, et al. Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. Embo j. 2018 Sep 3;37(17). doi: 10.15252/embj.201899238
   Web of Science ®Google Scholar
• Lam AR, Bert NL, Ho SS, et al. RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. Cancer Res. 2014 Apr 15;74(8):2193–2203.
   Web of Science ®Google Scholar
• Matsumoto K, Obana M, Kobayashi A, et al. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction. Cardiovasc Res. 2019 Mar 15;115(4):765–775.
   Web of Science ®Google Scholar
• Toldo S, Mauro AG, Cutter Z, et al. The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse. J Cardiovasc Pharmacol. 2019 Apr;73(4):215–222. doi: 10.1097/FJC.0000000000000658
   PubMed Web of Science ®Google Scholar
• Marchetti C, Toldo S, Chojnacki J, et al. Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse. J Cardiovasc Pharmacol. 2015 Jul;66(1):1–8. doi: 10.1097/FJC.0000000000000247
   PubMed Web of Science ®Google Scholar
• Liu Y, Lian K, Zhang L, et al. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2014;109(5):415. doi: 10.1007/s00395-014-0415-z.
   PubMed Web of Science ®Google Scholar
• Myung J, Beom JH, Kim JH, et al. Recombinant Klotho Protein Ameliorates Myocardial Ischemia/Reperfusion Injury by Attenuating Sterile Inflammation. Biomedicines. 2022 Apr 13;10(4). 894 10.3390/biomedicines10040894
   Web of Science ®Google Scholar
• Veltman D, Wu M, Pokreisz P, et al. Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury. JACC Basic Transl Sci. 2021 Aug;6(8):631–646. doi: 10.1016/j.jacbts.2021.07.001
   Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–1566.
   PubMed Web of Science ®Google Scholar
• Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006 Aug;7(8):589–600.
   PubMed Web of Science ®Google Scholar
• Mann DL. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res. 2015 Mar 27;116(7):1254–1268.
   Web of Science ®Google Scholar
• Chen WY, Hong J, Gannon J, et al. Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33. Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7249–7254.
   PubMed Web of Science ®Google Scholar
• O’Brien M, Baicu CF, Van Laer AO, et al. Pressure overload generates a cardiac-specific profile of inflammatory mediators. Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H331–H340.
   Web of Science ®Google Scholar
• Bossuyt J, Helmstadter K, Wu X, et al. Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ Res. 2008 Mar 28;102(6):695–702.
   Web of Science ®Google Scholar
• Sossalla S, Fluschnik N, Schotola H, et al. Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res. 2010 Oct 29;107(9):1150–1161.
   Web of Science ®Google Scholar
• Willeford A, Suetomi T, Nickle A, et al. CaMKIIdelta-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis. JCI Insight. 2018 Jun 21;3(12). doi: 10.1172/jci.insight.97054
   Web of Science ®Google Scholar
• Higashikuni Y, Liu W, Numata G, et al. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload. Circulation. 2023 Jan 24;147(4):338–355.
   Web of Science ®Google Scholar
• Suetomi T, Willeford A, Brand CS, et al. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca(2+)/Calmodulin-Dependent Protein Kinase II delta Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation. 2018 Nov 27;138(22):2530–2544. doi: 10.1161/CIRCULATIONAHA.118.034621
   PubMed Web of Science ®Google Scholar
• Yoshida K, Abe K, Ishikawa M, et al. Inhibition of TLR9-NF-κB-mediated sterile inflammation improves pressure overload-induced right ventricular dysfunction in rats. Cardiovasc Res. 2019 Mar 1;115(3):658–668.
   Web of Science ®Google Scholar
• Omiya S, Omori Y, Taneike M, et al. Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts. Circulation. 2020 Feb 25;141(8):667–677.
   Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia-and insulin-resistance-induced heart disease. Diabetologia. 2018 Jan;61(1):21–28.
   PubMed Web of Science ®Google Scholar
• Hofmann U, Frantz S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res. 2015 Jan 16;116(2):354–367.
   Web of Science ®Google Scholar
• McMaster WG, Kirabo A, Madhur MS, et al. Inflammation, immunity, and hypertensive end-organ damage. Circ Res. 2015 Mar 13;116(6):1022–1033.
   PubMed Web of Science ®Google Scholar
• SantaCruz-Calvo S, Bharath L, Pugh G, et al. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat Rev Endocrinol. 2022 Jan;18(1):23–42. doi: 10.1038/s41574-021-00575-1
   PubMed Web of Science ®Google Scholar
• Mori J, Alrob OA, Wagg CS, et al. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1103–H1113.
   PubMed Web of Science ®Google Scholar
• Tschope C, Walther T, Escher F, et al. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J. 2005 Dec;19(14):2057–2059. doi: 10.1096/fj.05-4095fje
   Google Scholar
• Luo B, Li B, Wang W, et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS One. 2014;9(8):e104771. doi: 10.1371/journal.pone.0104771
   PubMed Web of Science ®Google Scholar
• Luo B, Li B, Wang W, et al. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther. 2014 Feb;28(1):33–43. doi: 10.1007/s10557-013-6498-1
   PubMed Web of Science ®Google Scholar
• Ye Y, Bajaj M, Yang HC, et al. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor. Cardiovasc Drugs Ther. 2017 Apr;31(2):119–132. doi: 10.1007/s10557-017-6725-2
   PubMed Web of Science ®Google Scholar
• Shen L, Li L, Li M, et al. Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model. Int J Mol Med. 2018 Dec;42(6):3017–3026. doi: 10.3892/ijmm.2018.3880
   Web of Science ®Google Scholar
• Prieto P, Vallejo-Cremades MT, Benito G, et al. NOD1 receptor is up-regulated in diabetic human and murine myocardium. Clin Sci (Lond). 2014 Dec;127(12):665–677. doi: 10.1042/CS20140180
   Web of Science ®Google Scholar
• Li X, Du N, Zhang Q, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014 Oct 23;5(10):e1479–e1479.
   PubMedGoogle Scholar
• Xie Y, Huang Y, Ling X, et al. Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat. Front Physiol. 2020;11:381.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Cheh CW, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 2010 Sep 23;29(38):5299–5310.
   PubMed Web of Science ®Google Scholar
• Liu L, Yang M, Kang R, et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 2011 Jan;25(1):23–31. doi: 10.1038/leu.2010.225
   Web of Science ®Google Scholar
• Bianchi ME. HMGB1 loves company. J Leukoc Biol. 2009 Sep;86(3):573–576.
   PubMed Web of Science ®Google Scholar
• Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem. 2008 Nov 28;283(48):33175–33182.
   PubMed Web of Science ®Google Scholar
• Shi CS, Kehrl JH. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal. 2010 May 25;3(123):ra42.
   PubMed Web of Science ®Google Scholar
• Zalckvar E, Berissi H, Mizrachy L, et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep. 2009 Mar;10(3):285–292. doi: 10.1038/embor.2008.246
   PubMed Web of Science ®Google Scholar
• Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011 Apr;18(4):571–580. doi: 10.1038/cdd.2010.191
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010 Jan;11(1):55–62. doi: 10.1038/ni.1823
   PubMed Web of Science ®Google Scholar
• Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008 Nov 13;456(7219):2648.
   Web of Science ®Google Scholar
• Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012 Jan 29;13(3):255–263.
   PubMed Web of Science ®Google Scholar
• Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011 Mar;12(3):222–230. doi: 10.1038/ni.1980
   PubMed Web of Science ®Google Scholar
• Jounai N, Kobiyama K, Shiina M, et al. NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol. 2011 Feb 1;186(3):1646–1655.
   PubMed Web of Science ®Google Scholar
• Dupont N, Jiang S, Pilli M, et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011 Nov 8;30(23):4701–4711.
   PubMed Web of Science ®Google Scholar
• Pellegrini L, Foglio E, Pontemezzo E, et al. HMGB1 and repair: focus on the heart. Pharmacol Ther. 2019 Apr;196:160–182.
   PubMed Web of Science ®Google Scholar
• Volz HC, Seidel C, Laohachewin D, et al. HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res Cardiol. 2010 Nov;105(6):805–820. doi: 10.1007/s00395-010-0114-3
   PubMed Web of Science ®Google Scholar
• Banoth B, Cassel SL. Mitochondria in innate immune signaling. Transl Res. 2018 Dec;202:52–68.
   PubMed Web of Science ®Google Scholar
• Kitahara T, Takeishi Y, Harada M, et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res. 2008 Oct 1;80(1):40–46.
   PubMed Web of Science ®Google Scholar
• Bangert A, Andrassy M, Müller AM, et al. Critical role of RAGE and HMGB1 in inflammatory heart disease. Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E155–64.
   PubMed Web of Science ®Google Scholar
• Zhao W, Li Y, Jia L, et al. Atg5 deficiency-mediated mitophagy aggravates cardiac inflammation and injury in response to angiotensin II. Free Radic Biol Med. 2014 Apr;69:108–115.
   PubMed Web of Science ®Google Scholar
• Horckmans M, Ring L, Duchene J, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017 Jan 14;38(3):187–197.
   PubMed Web of Science ®Google Scholar
• Riffelmacher T, Clarke A, Richter FC, et al. Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation. Immunity. 2017 Sep 19;47(3):466–480 e5.
   PubMed Web of Science ®Google Scholar
• Reglero-Real N, Perez-Gutierrez L, Yoshimura A, et al. Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation. Immunity. 2021 Sep 14;54(9):1989–2004 e9.
   PubMed Web of Science ®Google Scholar
• Steffens S, Nahrendorf M, Madonna R. Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies. Eur Heart J. 2022 Apr 19;43(16):1533–1541.
   Web of Science ®Google Scholar
• Javaheri A, Bajpai G, Picataggi A, et al. TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy. JCI Insight. 2019 Nov 1;4(21). doi: 10.1172/jci.insight.127312
   Web of Science ®Google Scholar
• Gong N, Yang X, Li X, et al. MicroRNA-590-3p relieves hypoxia/reoxygenation induced cardiomyocytes apoptosis and autophagy by targeting HIF-1α. Exp Ther Med. 2021 Oct;22(4):1077. doi: 10.3892/etm.2021.10511
   Web of Science ®Google Scholar
• Li Z, Song Y, Liu L, et al. miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ. 2017 Jul;24(7):1205–1213. doi: 10.1038/cdd.2015.95
   PubMed Web of Science ®Google Scholar
• Ning S, Li Z, Ji Z, et al. MicroRNA‑494 suppresses hypoxia/reoxygenation‑induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1. Mol Med Rep. 2020 Dec;22(6):5231–5242. doi: 10.3892/mmr.2020.11636
   PubMed Web of Science ®Google Scholar
• Qiu R, Li W, Liu Y. MicroRNA-204 protects H9C2 cells against hypoxia/reoxygenation-induced injury through regulating SIRT1-mediated autophagy. Biomed Pharmacother. 2018 Apr;100:15–19.
   PubMed Web of Science ®Google Scholar
• Wang F, Min X, Hu SY, et al. Hypoxia/reoxygenation-induced upregulation of miRNA-542-5p aggravated cardiomyocyte injury by repressing autophagy. Hum Cell. 2021 Mar;34(2):349–359. doi: 10.1007/s13577-020-00466-z
   Web of Science ®Google Scholar
• Wu K, Chen Y, Wang D, et al. MicroRNA-520d-3p alleviates hypoxia/reoxygenation-induced damage in human cardiomyocytes by targeting ATG-12. J Thromb Thrombolysis. 2021 Aug;52(2):429–439. doi: 10.1007/s11239-020-02352-9
   Web of Science ®Google Scholar
• Zhang Y, Zhan B, Hu Y, et al. Sevoflurane inhibits the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes via regulating miR-27a-3p-mediated autophagy. J Pharm Pharmacol. 2021 Oct 7;73(11):1470–1479.
   Web of Science ®Google Scholar
• Zhou K, Xu Y, Wang Q, et al. Overexpression of miR-431 attenuates hypoxia/reoxygenation-induced myocardial damage via autophagy-related 3. Acta Biochim Biophys Sin (Shanghai). 2021 Feb 4;53(2):140–148.
   Web of Science ®Google Scholar
• Hu X, Zhang K, Chen Z, et al. The HMGB1‑IL‑17A axis contributes to hypoxia/reoxygenation injury via regulation of cardiomyocyte apoptosis and autophagy. Mol Med Rep. 2018 Jan;17(1):336–341. doi: 10.3892/mmr.2017.7839
   PubMed Web of Science ®Google Scholar
• Lu S, Yu L, Liu H. Trimetazidine alleviates hypoxia/reoxygenation-induced apoptosis in neonatal mice cardiomyocytes via up-regulating HMGB1 expression to promote autophagy. J Recept Signal Transduct Res. 2021 Apr;41(2):170–179.
   PubMed Web of Science ®Google Scholar
• Luo C, Zhang Y, Guo H, et al. Ferulic Acid Attenuates Hypoxia/Reoxygenation Injury by Suppressing Mitophagy Through the PINK1/Parkin Signaling Pathway in H9c2 Cells. Front Pharmacol. 2020;11:103.
   Web of Science ®Google Scholar
• Sun L, Zhao M, Yang Y, et al. Acetylcholine Attenuates Hypoxia/Reoxygenation Injury by Inducing Mitophagy Through PINK1/Parkin Signal Pathway in H9c2 Cells. J Cell Physiol. 2016 May;231(5):1171–1181. doi: 10.1002/jcp.25215
   Web of Science ®Google Scholar
• Chen X, Li X, Zhang W, et al. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 2018 Jun;83:256–270.
   PubMed Web of Science ®Google Scholar
• Takikawa T, Ohashi K, Ogawa H, et al. Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction. PLoS One. 2020;15(12):e0243483. doi: 10.1371/journal.pone.0243483
   Web of Science ®Google Scholar
• Jin AP, Zhang QR, Yang CL, et al. Up-regulation of CTRP12 ameliorates hypoxia/re-oxygenation-induced cardiomyocyte injury by inhibiting apoptosis, oxidative stress, and inflammation via the enhancement of Nrf2 signaling. Hum Exp Toxicol. 2021 Dec;40(12):2087–2098. doi: 10.1177/09603271211021880
   Web of Science ®Google Scholar
• Oka T, Hikoso S, Yamaguchi O, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012 May 10;485(7397):251–255.
   PubMed Web of Science ®Google Scholar
• Stunz LL, Lenert P, Peckham D, et al. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol. 2002 May;32(5):1212–1222. doi: 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D
   Web of Science ®Google Scholar
• Poole AC, Thomas RE, Yu S, et al. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One. 2010 Apr 7;5(4):e10054.
   PubMed Web of Science ®Google Scholar
• Xu A, Sweeney G. Emerging role of autophagy in mediating widespread actions of ADIPOQ/adiponectin. Autophagy. 2015 Apr 3;11(4):723–724.
   PubMed Web of Science ®Google Scholar
• Caselli C, D’Amico A, Cabiati M, et al. Back to the heart: the protective role of adiponectin. Pharmacol Res. 2014 Apr;82:9–20.
   PubMed Web of Science ®Google Scholar
• Luo Y, Liu M. Adiponectin: a versatile player of innate immunity. J Mol Cell Biol. 2016 Apr;8(2):120–128.
   Web of Science ®Google Scholar
• Yamaguchi N, Argueta JG, Masuhiro Y, et al. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett. 2005 Dec 19;579(30):6821–6826.
   Web of Science ®Google Scholar
• Park PH, Huang H, McMullen MR, et al. Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages. J Leukoc Biol. 2008 May;83(5):1258–1266. doi: 10.1189/jlb.0907631
   Web of Science ®Google Scholar
• Ohashi K, Parker JL, Ouchi N, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010 Feb 26;285(9):6153–6160.
   PubMed Web of Science ®Google Scholar
• Hui X, Gu P, Zhang J, et al. Adiponectin Enhances Cold-Induced Browning of Subcutaneous Adipose Tissue via Promoting M2 Macrophage Proliferation. Cell Metab. 2015 Aug 4;22(2):279–290.
   Web of Science ®Google Scholar
• Liu Y, Vu V, Sweeney G. Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases. Front Endocrinol (Lausanne). 2019;10:842.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yuan M, Zhang L, et al. Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis. Biochem Biophys Res Commun. 2019 Jun 18;514(1):266–272.
   PubMed Web of Science ®Google Scholar
• Ren J, Xu X, Wang Q, et al. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia. J Mol Cell Cardiol. 2016 Apr;93:18–31.
   Web of Science ®Google Scholar
• Everett BM, MacFadyen JG, Thuren T, et al. Inhibition of Interleukin-1beta and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial. J Am Coll Cardiol. 2020 Oct 6;76(14):1660–1670.
   PubMed Web of Science ®Google Scholar
• Klein AL, Imazio M, Cremer P, et al. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med. 2021 Jan 7;384(1):31–41.
   PubMed Web of Science ®Google Scholar
• Abbate A, Wohlford GF, Del Buono MG, et al. Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):503–510.
   Web of Science ®Google Scholar
• Abbate A, Trankle CR, Buckley LF, et al. Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc. 2020 Mar 3;9(5):e014941.
   PubMed Web of Science ®Google Scholar
• Farag A, Mandour AS, Kaneda M, et al. Effect of trehalose on heart functions in rats model after myocardial infarction: assessment of novel intraventricular pressure and heart rate variability. Front Cardiovasc Med. 2023;10:1182628.
   Google Scholar
• Jamialahmadi T, Emami F, Bagheri RK, et al. The effect of trehalose administration on vascular inflammation in patients with coronary artery disease. Biomed Pharmacother. 2022 Mar;147:112632.
   Web of Science ®Google Scholar
• Oesterle A, Laufs U, Liao JK. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res. 2017 Jan 6;120(1):229–243.
   PubMed Web of Science ®Google Scholar
• Andres AM, Hernandez G, Lee P, et al. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid Redox Signal. 2014 Nov 10;21(14):1960–1973.
   PubMed Web of Science ®Google Scholar
• Li X, Liu J, Lu Q, et al. AMPK: a therapeutic target of heart failure-not only metabolism regulation. Biosci Rep. 2019 Jan 31;39(1):BSR20181767.
   Google Scholar
• Wang B, Nie J, Wu L, et al. AMPKalpha2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation. Circ Res. 2018 Mar 2;122(5):712–729.
   PubMed Web of Science ®Google Scholar
• Koyani CN, Plastira I, Sourij H, et al. Empagliflozin protects heart from inflammation and energy depletion via AMPK activation. Pharmacol Res. 2020 Aug;158:104870.
   PubMed Web of Science ®Google Scholar
• Cusi K, Alkhouri N, Harrison SA, et al. Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):889–902. doi: 10.1016/S2468-1253(21)00300-9
   Web of Science ®Google Scholar
• Stephan Y, Souille M, Larcheveque M, et al. Both short-and long-term treatment with the direct AMP kinase activator PXL770 improves cardiac function in ZSF-1 rats. Eur Heart J. 2021;42(1):ehab724.1050. doi: 10.1093/eurheartj/ehab724.1050
   Google Scholar